3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
3
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Gastrointestinal
1
Conditions
Lymphoma
3
Lymphoma, Large B-Cell, Diffuse
2
Venous Thromboembolism
1
Thromboembolism
1
Pulmonary Embolism
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Immunoblastic Lymphadenopathy
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Burkitt Lymphoma
1
Interventions
enoxaparin sodium
1
apixaban
1
Rivaroxaban
1
Heparin, Low-Molecular-Weight
1
Enoxaparin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pulmonary Embolism
×
Enoxaparin
×
Lymphoid
×
Clear all
NCT07270263
2025-12-26
HEM-DOAC
Medical University of Gdansk
Phase NA
Recruiting
100 enrolled